Patent · US Active

Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases

US11439628B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Peter Sandner · Wuppertal, DE
Peter Kolkhof · Wuppertal, DE
Ilka MATHAR · Düsseldorf, DE
Stefanie Breitenstein · Düsseldorf, DE

Key dates

Filing date	May 10, 2019
Grant date	Sep 13, 2022
Priority date	—
Expiry date	May 10, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P21/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to non-steriodal mineralocorticoid receptor (MR) and the pharmacology of mineralocorticoid receptor antagonists (MR Antagonists, MRAs). In particular, the invention relates to the use of MRAs alone and in combination preferably in combination with sGC stimulators and/or sGC activators for preparation of medicaments for the prevention and/or treatment of muscular or neuromuscular diseases, especially for the treatment of Duchenne Muscular Dystrophy (DMD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.